Recursion Pharmaceuticals, Inc. ( RXRX) - Stock Earnings
RXRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -108.1 million USD | 35.5 million USD |
| 2026Q1 | -117.5 million USD | 6.5 million USD |
| 2026Q2 | -131.0 million USD | 7.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
RXRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -328.1 million USD | 43.9 million USD |
| 2024 | -463.7 million USD | 58.8 million USD |
| 2025 | -644.8 million USD | 74.7 million USD |
| 2026 Est. | — | — |
RXRX
Price: $3.16
52 week price:
Earnings Per Share: -1.02 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 732400
Market Capitalization: 1.8 billion